Cargando…

EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3)

SIMPLE SUMMARY: The Epstein–Barr virus (EBV) is a commonly occurring virus, infecting more than 90% of the world population, often early in life. However, only a minority of individuals develop EBV-driven diseases at some point in their lifetime. EBV is associated with several neoplasms including ep...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanelli, Magda, Sanguedolce, Francesca, Palicelli, Andrea, Zizzo, Maurizio, Martino, Giovanni, Caprera, Cecilia, Fragliasso, Valentina, Soriano, Alessandra, Gozzi, Fabrizio, Cimino, Luca, Masia, Francesco, Moretti, Marina, Foroni, Moira, De Marco, Loredana, Pellegrini, David, De Raeve, Hendrik, Ricci, Stefano, Tamagnini, Ione, Tafuni, Alessandro, Cavazza, Alberto, Merli, Francesco, Pileri, Stefano A., Ascani, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656853/
https://www.ncbi.nlm.nih.gov/pubmed/34885131
http://dx.doi.org/10.3390/cancers13236021
_version_ 1784612381470490624
author Zanelli, Magda
Sanguedolce, Francesca
Palicelli, Andrea
Zizzo, Maurizio
Martino, Giovanni
Caprera, Cecilia
Fragliasso, Valentina
Soriano, Alessandra
Gozzi, Fabrizio
Cimino, Luca
Masia, Francesco
Moretti, Marina
Foroni, Moira
De Marco, Loredana
Pellegrini, David
De Raeve, Hendrik
Ricci, Stefano
Tamagnini, Ione
Tafuni, Alessandro
Cavazza, Alberto
Merli, Francesco
Pileri, Stefano A.
Ascani, Stefano
author_facet Zanelli, Magda
Sanguedolce, Francesca
Palicelli, Andrea
Zizzo, Maurizio
Martino, Giovanni
Caprera, Cecilia
Fragliasso, Valentina
Soriano, Alessandra
Gozzi, Fabrizio
Cimino, Luca
Masia, Francesco
Moretti, Marina
Foroni, Moira
De Marco, Loredana
Pellegrini, David
De Raeve, Hendrik
Ricci, Stefano
Tamagnini, Ione
Tafuni, Alessandro
Cavazza, Alberto
Merli, Francesco
Pileri, Stefano A.
Ascani, Stefano
author_sort Zanelli, Magda
collection PubMed
description SIMPLE SUMMARY: The Epstein–Barr virus (EBV) is a commonly occurring virus, infecting more than 90% of the world population, often early in life. However, only a minority of individuals develop EBV-driven diseases at some point in their lifetime. EBV is associated with several neoplasms including epithelial, mesenchymal and lymphoid tumors. EBV-driven lymphoid proliferations encompass a wide spectrum of diseases with different biological behaviors, developing frequently, although not always, in conditions of immunosuppression. The diagnosis is often complicated and requires a strict combination of clinical, pathological and molecular findings. The aim of this review, divided into three parts, is to provide an update on EBV-driven lymphoproliferative disorders arising in the gastrointestinal tract. In this review, we discuss the chronic active EBV infection of T-cell and NK-cell type, its systemic form; extranodal NK/T-cell lymphoma, nasal type and post-transplant lymphoproliferative disorders. ABSTRACT: EBV is the first known oncogenic virus involved in the development of several tumors. The majority of the global population are infected with the virus early in life and the virus persists throughout life, in a latent stage, and usually within B lymphocytes. Despite the worldwide diffusion of EBV infection, EBV-associated diseases develop in only in a small subset of individuals often when conditions of immunosuppression disrupt the balance between the infection and host immune system. EBV-driven lymphoid proliferations are either of B-cell or T/NK-cell origin, and range from disorders with an indolent behavior to aggressive lymphomas. In this review, which is divided in three parts, we provide an update of EBV-associated lymphoid disorders developing in the gastrointestinal tract, often representing a challenging diagnostic and therapeutic issue. Our aim is to provide a practical diagnostic approach to clinicians and pathologists who face this complex spectrum of disorders in their daily practice. In this part of the review, the chronic active EBV infection of T-cell and NK-cell type, its systemic form; extranodal NK/T-cell lymphoma, nasal type and post-transplant lymphoproliferative disorders are discussed.
format Online
Article
Text
id pubmed-8656853
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86568532021-12-10 EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3) Zanelli, Magda Sanguedolce, Francesca Palicelli, Andrea Zizzo, Maurizio Martino, Giovanni Caprera, Cecilia Fragliasso, Valentina Soriano, Alessandra Gozzi, Fabrizio Cimino, Luca Masia, Francesco Moretti, Marina Foroni, Moira De Marco, Loredana Pellegrini, David De Raeve, Hendrik Ricci, Stefano Tamagnini, Ione Tafuni, Alessandro Cavazza, Alberto Merli, Francesco Pileri, Stefano A. Ascani, Stefano Cancers (Basel) Review SIMPLE SUMMARY: The Epstein–Barr virus (EBV) is a commonly occurring virus, infecting more than 90% of the world population, often early in life. However, only a minority of individuals develop EBV-driven diseases at some point in their lifetime. EBV is associated with several neoplasms including epithelial, mesenchymal and lymphoid tumors. EBV-driven lymphoid proliferations encompass a wide spectrum of diseases with different biological behaviors, developing frequently, although not always, in conditions of immunosuppression. The diagnosis is often complicated and requires a strict combination of clinical, pathological and molecular findings. The aim of this review, divided into three parts, is to provide an update on EBV-driven lymphoproliferative disorders arising in the gastrointestinal tract. In this review, we discuss the chronic active EBV infection of T-cell and NK-cell type, its systemic form; extranodal NK/T-cell lymphoma, nasal type and post-transplant lymphoproliferative disorders. ABSTRACT: EBV is the first known oncogenic virus involved in the development of several tumors. The majority of the global population are infected with the virus early in life and the virus persists throughout life, in a latent stage, and usually within B lymphocytes. Despite the worldwide diffusion of EBV infection, EBV-associated diseases develop in only in a small subset of individuals often when conditions of immunosuppression disrupt the balance between the infection and host immune system. EBV-driven lymphoid proliferations are either of B-cell or T/NK-cell origin, and range from disorders with an indolent behavior to aggressive lymphomas. In this review, which is divided in three parts, we provide an update of EBV-associated lymphoid disorders developing in the gastrointestinal tract, often representing a challenging diagnostic and therapeutic issue. Our aim is to provide a practical diagnostic approach to clinicians and pathologists who face this complex spectrum of disorders in their daily practice. In this part of the review, the chronic active EBV infection of T-cell and NK-cell type, its systemic form; extranodal NK/T-cell lymphoma, nasal type and post-transplant lymphoproliferative disorders are discussed. MDPI 2021-11-30 /pmc/articles/PMC8656853/ /pubmed/34885131 http://dx.doi.org/10.3390/cancers13236021 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Zanelli, Magda
Sanguedolce, Francesca
Palicelli, Andrea
Zizzo, Maurizio
Martino, Giovanni
Caprera, Cecilia
Fragliasso, Valentina
Soriano, Alessandra
Gozzi, Fabrizio
Cimino, Luca
Masia, Francesco
Moretti, Marina
Foroni, Moira
De Marco, Loredana
Pellegrini, David
De Raeve, Hendrik
Ricci, Stefano
Tamagnini, Ione
Tafuni, Alessandro
Cavazza, Alberto
Merli, Francesco
Pileri, Stefano A.
Ascani, Stefano
EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3)
title EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3)
title_full EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3)
title_fullStr EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3)
title_full_unstemmed EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3)
title_short EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3)
title_sort ebv-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: a spectrum of entities with a common denominator (part 3)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656853/
https://www.ncbi.nlm.nih.gov/pubmed/34885131
http://dx.doi.org/10.3390/cancers13236021
work_keys_str_mv AT zanellimagda ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT sanguedolcefrancesca ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT palicelliandrea ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT zizzomaurizio ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT martinogiovanni ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT capreracecilia ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT fragliassovalentina ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT sorianoalessandra ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT gozzifabrizio ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT ciminoluca ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT masiafrancesco ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT morettimarina ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT foronimoira ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT demarcoloredana ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT pellegrinidavid ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT deraevehendrik ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT riccistefano ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT tamagniniione ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT tafunialessandro ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT cavazzaalberto ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT merlifrancesco ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT pileristefanoa ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3
AT ascanistefano ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3